G826-0674 Screening compound: 2-{4-[(3,4-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide

G826-0674 Screening compound: 2-{4-[(3,4-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide
G826-0674 Screening compound: 2-{4-[(3,4-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G826-0674
2-{4-[(3,4-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G826-0674

Molecular Formula

C25H24F2N4O3 (C25 H24 F2 N4 O3)

Compound Name

2-{4-[(3,4-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide

IUPAC name

2-{4-[(34-difluorophenyl)carbamoyl]piperidin-1-yl}-N-(3-methoxyphenyl)pyridine-4-carboxamide

SMILES

COc1cccc(NC(c2cc(N(CC3)CCC3C(Nc(cc3)cc(F)c3F)=O)ncc2)=O)c1

InChI

InChI=1S/C25H24F2N4O3/c1-34-20-4-2-3-18(14-20)29-25(33)17-7-10-28-23(13-17)31-11-8-16(9-12-31)24(32)30-19-5-6-21(26)22(27)15-19/h2-7,10,13-16H,8-9,11-12H2,1H3,(H,29,33)(H,30,32)

InChI Key

NMNMFEMWUIZUDD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15039404

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.472

Distribution Coefficient, logD

4.430

Water Solubility, LogSw

-4.34

Polar Surface Area

65.928

Acid Dissociation Constant (pKa)

8.40

Base Dissociation Constant (pKb)

8.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

G826-0674 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G826-0674 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G826-0674?
Check Price and Availability of G826-0674, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G826-0674 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G826-0674
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G826-0674
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G826-0674 available by request